Cito Capital Group, LLC Bausch Health Companies Inc. Transaction History

Cito Capital Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $205,200 - $264,500	-10,000 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$20.23 - $26.29 $60,690 - $78,870	-3,000 Reduced 23.08%	10,000 $247,000
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $268,320 - $333,710	13,000 New	13,000 $334,000

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Cito Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cito Capital Group, LLC with notifications on news.